{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:16:23Z","timestamp":1792790183272,"version":"4.5.0"},"reference-count":190,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T00:00:00Z","timestamp":1712620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Sanofi Vaccines"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>The optimal immune response eliminates invading pathogens, restoring immune equilibrium without inflicting undue harm to the host. However, when a cascade of immunological reactions is triggered, the immune response can sometimes go into overdrive, potentially leading to harmful long-term effects or even death. The immune system is triggered mostly by infections, allergens, or medical interventions such as vaccination. This review examines how these immune triggers differ and why certain infections may dysregulate immune homeostasis, leading to inflammatory or allergic pathology and exacerbation of pre-existing conditions. However, many vaccines generate an optimal immune response and protect against the consequences of pathogen-induced immunological aggressiveness, and from a small number of unrelated pathogens and autoimmune diseases. Here, we propose an \u201cimmuno-wave\u201d model describing a vaccine-induced \u201cGoldilocks immunity\u201d, which leaves fine imprints of both pro-inflammatory and anti-inflammatory milieus, derived from both the innate and the adaptive arms of the immune system, in the body. The resulting balanced, \u2018quiet alert\u2019 state of the immune system may provide a jump-start in the defense against pathogens and any associated pathological inflammatory or allergic responses, allowing vaccines to go above and beyond their call of duty. In closing, we recommend formally investigating and reaping many of the secondary benefits of vaccines with appropriate clinical studies.<\/jats:p>","DOI":"10.3390\/vaccines12040396","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T08:55:12Z","timestamp":1712652912000},"page":"396","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Vaccines Induce Homeostatic Immunity, Generating Several Secondary Benefits"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6486-5722","authenticated-orcid":false,"given":"Arun B.","family":"Arunachalam","sequence":"first","affiliation":[{"name":"Analytical Sciences, R&D Sanofi Vaccines, 1 Discovery Dr., Swiftwater, PA 18370, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41577-020-0391-5","article-title":"Constitutive immune mechanisms: Mediators of host defence and immune regulation","volume":"21","author":"Paludan","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine Storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining trained immunity and its role in health and disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/ni.3790","article-title":"A guiding map for inflammation","volume":"18","author":"Netea","year":"2017","journal-title":"Nat. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","article-title":"Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins","volume":"136","author":"Mosmann","year":"1986","journal-title":"J. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0167-5699(87)90171-X","article-title":"Two types of mouse helper T-cell clone Implications for immune regulation","volume":"8","author":"Mosmann","year":"1987","journal-title":"Immunol. Today"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1178334","article-title":"Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells","volume":"327","author":"Paul","year":"2010","journal-title":"Science"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/ni.2404","article-title":"Maintaining system homeostasis: The third law of Newtonian immunology","volume":"13","author":"Germain","year":"2012","journal-title":"Nat. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.immuni.2015.06.003","article-title":"Proteolytic Processing of Interleukin-1 Family Cytokines: Variations on a Common Theme","volume":"42","author":"Afonina","year":"2015","journal-title":"Immunity"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: A program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41590-020-00845-6","article-title":"Trained immunity, tolerance, priming and differentiation: Distinct immunological processes","volume":"22","author":"Divangahi","year":"2021","journal-title":"Nat. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/s41385-022-00557-0","article-title":"Trained immunity in type 2 immune responses","volume":"15","author":"Hartung","year":"2022","journal-title":"Mucosal Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev-immunol-032712-095910","article-title":"Pathways of antigen processing","volume":"31","author":"Blum","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41577-022-00707-2","article-title":"A guide to antigen processing and presentation","volume":"22","author":"Pishesha","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nri.2017.50","article-title":"The dichotomous nature of T helper 17 cells","volume":"17","author":"Stockinger","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","article-title":"Follicular helper CD4 T cells (TFH)","volume":"29","author":"Crotty","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nri3447","article-title":"The good, the bad and the ugly\u2014TFH cells in human health and disease","volume":"13","author":"Tangye","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.it.2014.06.002","article-title":"Phenotype and functions of memory Tfh cells in human blood","volume":"35","author":"Schmitt","year":"2014","journal-title":"Trends Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s10875-016-0268-3","article-title":"Human Circulating T Follicular Helper Cell Subsets in Health and Disease","volume":"36","author":"Ueno","year":"2016","journal-title":"J. Clin. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/ni.3054","article-title":"Pathophysiology of T follicular helper cells in humans and mice","volume":"16","author":"Ueno","year":"2015","journal-title":"Nat. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/SQB.1989.054.01.003","article-title":"Approaching the asymptote? Evolution and revolution in immunology","volume":"54","author":"Janeway","year":"1989","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1006\/smim.1998.0143","article-title":"An innate sense of danger","volume":"10","author":"Matzinger","year":"1998","journal-title":"Semin. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.4049\/jimmunol.140.12.4245","article-title":"Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones","volume":"140","author":"Gajewski","year":"1988","journal-title":"J. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.4049\/jimmunol.145.11.3796","article-title":"IL-4 directs the development of Th2-like helper effectors","volume":"145","author":"Swain","year":"1990","journal-title":"J. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0008-8749(74)90237-8","article-title":"On the control between cell-mediated, IgM and IgG immunity","volume":"13","author":"Bretscher","year":"1974","journal-title":"Cell Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1086\/317537","article-title":"Type 1\/Type 2 immunity in infectious diseases","volume":"32","author":"Spellberg","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Lee, G.R. (2018). The Balance of Th17 versus Treg Cells in Autoimmunity. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19030730"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: From T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fimmu.2020.00487","article-title":"The Role of PD-1 in Acute and Chronic Infection","volume":"11","author":"Jubel","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/1074-7613(94)90071-X","article-title":"CTLA-4 can function as a negative regulator of T cell activation","volume":"1","author":"Walunas","year":"1994","journal-title":"Immunity"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.182.2.459","article-title":"CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation","volume":"182","author":"Krummel","year":"1995","journal-title":"J. Exp. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1126\/science.1160062","article-title":"CTLA-4 control over Foxp3+ regulatory T cell function","volume":"322","author":"Wing","year":"2008","journal-title":"Science"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1073\/pnas.0910341107","article-title":"Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity","volume":"107","author":"Jain","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","article-title":"Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation","volume":"192","author":"Freeman","year":"2000","journal-title":"J. Exp. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/83118","article-title":"The Goldilocks conditions applied to T cell development","volume":"2","author":"Yun","year":"2001","journal-title":"Nat. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00296-020-04636-y","article-title":"Hemophagocytic lymphohistiocytosis: A review inspired by the COVID-19 pandemic","volume":"41","author":"Soy","year":"2021","journal-title":"Rheumatol. Int."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/art.40071","article-title":"Review: Cytokine Storm Syndrome: Looking Toward the Precision Medicine Era","volume":"69","author":"Behrens","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.it.2021.06.001","article-title":"The \u2018cytokine storm\u2019: Molecular mechanisms and therapeutic prospects","volume":"42","author":"Karki","year":"2021","journal-title":"Trends Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-med-061512-150641","article-title":"IL-1 blockade in autoinflammatory syndromes","volume":"65","author":"Jesus","year":"2014","journal-title":"Annu. Rev. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"101515","DOI":"10.1016\/j.berh.2020.101515","article-title":"Hemophagocytic lymphohistiocytosis: An update on pathogenesis, diagnosis, and therapy","volume":"34","author":"Griffin","year":"2020","journal-title":"Best. Pract. Res. Clin. Rheumatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"614704","DOI":"10.3389\/fimmu.2021.614704","article-title":"Use of the JAK Inhibitor Ruxolitinib in the Treatment of Hemophagocytic Lymphohistiocytosis","volume":"12","author":"Keenan","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_42","unstructured":"Nash, A.A., Dalziel, R.G., and Fitzgerald, J.R. (2015). Mims\u2019 Pathogenesis of Infectious Disease, Elsevier."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"a021378","DOI":"10.1101\/cshperspect.a021378","article-title":"Hepatitis B Virus and Hepatitis D Virus Entry, Species Specificity, and Tissue Tropism","volume":"5","author":"Watashi","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41577-021-00549-4","article-title":"Immunobiology and pathogenesis of hepatitis B virus infection","volume":"22","author":"Iannacone","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41579-021-00542-7","article-title":"Influenza virus and SARS-CoV-2: Pathogenesis and host responses in the respiratory tract","volume":"19","author":"Flerlage","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nri2802","article-title":"Immunity and immunopathology to viruses: What decides the outcome?","volume":"10","author":"Rouse","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/aje\/kwm375","article-title":"Time lines of infection and disease in human influenza: A review of volunteer challenge studies","volume":"167","author":"Carrat","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","article-title":"Macrophages in Tissue Repair, Regeneration, and Fibrosis","volume":"44","author":"Wynn","year":"2016","journal-title":"Immunity"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00011-016-0996-0","article-title":"The inflammatory response triggered by Influenza virus: A two edged sword","volume":"66","author":"Tavares","year":"2017","journal-title":"Inflamm. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ijcard.2008.04.044","article-title":"Cardiovascular manifestations associated with influenza virus infection","volume":"130","author":"Mamas","year":"2008","journal-title":"Int. J. Cardiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/irv.12470","article-title":"The hidden burden of influenza: A review of the extra-pulmonary complications of influenza infection","volume":"11","author":"Sellers","year":"2017","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1111\/febs.16363","article-title":"Nonrespiratory sites of influenza-associated disease: Mechanisms and experimental systems for continued study","volume":"289","author":"Froggatt","year":"2022","journal-title":"FEBS J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"121ps123","DOI":"10.1126\/scitranslmed.3003492","article-title":"Viral and inflammatory triggers of neurodegenerative diseases","volume":"4","author":"Deleidi","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"eabm5505","DOI":"10.1126\/sciimmunol.abm5505","article-title":"Innate immunological pathways in COVID-19 pathogenesis","volume":"7","author":"Paludan","year":"2022","journal-title":"Sci. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"101783","DOI":"10.1016\/j.eclinm.2022.101783","article-title":"Risk of autoimmune diseases in patients with COVID-19: A retrospective cohort study","volume":"56","author":"Chang","year":"2023","journal-title":"EClinicalMedicine"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJMra032015","article-title":"Persistence of the Epstein-Barr virus and the origins of associated lymphomas","volume":"350","author":"Gross","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3389\/fnins.2019.01026","article-title":"Cerebrospinal Fluid and Blood Cytokines as Biomarkers for Multiple Sclerosis: A Systematic Review and Meta-Analysis of 226 Studies With 13,526 Multiple Sclerosis Patients","volume":"13","author":"Bai","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41586-022-04702-4","article-title":"Fc\u03b3R-mediated SARS-CoV-2 infection of monocytes activates inflammation","volume":"606","author":"Junqueira","year":"2022","journal-title":"Nature"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: Mechanism of action, role in disease, and therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-2796.2008.02043.x","article-title":"Immune dysregulation in human immunodeficiency virus infection: Know it, fix it, prevent it?","volume":"265","author":"Boasso","year":"2009","journal-title":"J. Intern. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"731845","DOI":"10.3389\/fimmu.2021.731845","article-title":"Superantigen Recognition and Interactions: Functions, Mechanisms and Applications","volume":"12","author":"Deacy","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","article-title":"Interaction between microbiota and immunity in health and disease","volume":"30","author":"Zheng","year":"2020","journal-title":"Cell Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.vaccine.2018.12.005","article-title":"Would immunization be the same without cross-reactivity?","volume":"37","author":"Vojtek","year":"2019","journal-title":"Vaccine"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"eabd6160","DOI":"10.1126\/sciimmunol.abd6160","article-title":"SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection","volume":"5","author":"Altmann","year":"2020","journal-title":"Sci. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41577-022-00809-x","article-title":"The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses","volume":"23","author":"Murray","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.vaccine.2005.10.051","article-title":"Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus","volume":"24","author":"Lee","year":"2006","journal-title":"Vaccine"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"8067","DOI":"10.1016\/j.vaccine.2007.09.012","article-title":"Immediate and broad-spectrum protection against heterologous and heterotypic lethal challenge in mice by live influenza vaccine","volume":"25","author":"Seo","year":"2007","journal-title":"Vaccine"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.1128\/JVI.07149-11","article-title":"Cold-adapted pandemic 2009 H1N1 influenza virus live vaccine elicits cross-reactive immune responses against seasonal and H5 influenza A viruses","volume":"86","author":"Jang","year":"2012","journal-title":"J. Virol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1080\/14760584.2017.1379396","article-title":"Vaccine approaches conferring cross-protection against influenza viruses","volume":"16","author":"Vemula","year":"2017","journal-title":"Expert. Rev. Vaccines"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev-med-120617-041310","article-title":"Is a Universal Influenza Virus Vaccine Possible?","volume":"71","author":"Nachbagauer","year":"2020","journal-title":"Annu. Rev. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41573-019-0056-x","article-title":"Next-generation influenza vaccines: Opportunities and challenges","volume":"19","author":"Wei","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e2123477119","DOI":"10.1073\/pnas.2123477119","article-title":"Researchers getting closer to a \u201cuniversal\u201d flu vaccine","volume":"119","author":"Beans","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12985-017-0918-y","article-title":"Towards a universal influenza vaccine: Different approaches for one goal","volume":"15","author":"Sautto","year":"2018","journal-title":"Virol. J."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41591-020-1118-7","article-title":"A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial","volume":"27","author":"Nachbagauer","year":"2021","journal-title":"Nat. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41541-021-00403-7","article-title":"Unique features of a recombinant haemagglutinin influenza vaccine that influence vaccine performance","volume":"6","author":"Arunachalam","year":"2021","journal-title":"NPJ Vaccines"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.it.2013.04.004","article-title":"A small jab\u2014A big effect: Nonspecific immunomodulation by vaccines","volume":"34","author":"Benn","year":"2013","journal-title":"Trends Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.smim.2018.06.002","article-title":"Non-specific effects of vaccines: Current evidence and potential implications","volume":"39","author":"Koeken","year":"2018","journal-title":"Semin. Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1439-0450.2004.00763.x","article-title":"Taking advantage of the positive side-effects of smallpox vaccination","volume":"51","author":"Mayr","year":"2004","journal-title":"J. Vet. Med. B Infect. Dis. Vet. Public. Health"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/ije\/dyr063","article-title":"Smallpox vaccination and all-cause infectious disease hospitalization: A Danish register-based cohort study","volume":"40","author":"Sorup","year":"2011","journal-title":"Int. J. Epidemiol."},{"key":"ref_81","unstructured":"Naeslund, C. (1932). Vaccination Pre\u00b4Ventative de la Tuberculose de l Homme et des Animaux par le BCG: Rapports et Documents Provenant des Divers Pays (la France Excepte\u00b4e), Masson."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: A meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J. Urol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41541-018-0062-8","article-title":"Long-term reduction in hyperglycemia in advanced type 1 diabetes: The value of induced aerobic glycolysis with BCG vaccinations","volume":"3","author":"Kuhtreiber","year":"2018","journal-title":"NPJ Vaccines"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Dow, C.T., Greenblatt, C.L., Chan, E.D., and Dow, J.F. (2022). Evaluation of BCG Vaccination and Plasma Amyloid: A Prospective, Pilot Study with Implications for Alzheimer\u2019s Disease. Microorganisms, 10.","DOI":"10.3390\/microorganisms10020424"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/infdis\/jis597","article-title":"Influenza infection and risk of acute myocardial infarction in England and Wales: A CALIBER self-controlled case series study","volume":"206","author":"Hayward","year":"2012","journal-title":"J. Infect. Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"583","DOI":"10.7326\/L21-0018","article-title":"Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults","volume":"174","author":"Chow","year":"2021","journal-title":"Ann. Intern. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa1702090","article-title":"Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection","volume":"378","author":"Kwong","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1701794","DOI":"10.1183\/13993003.01794-2017","article-title":"Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: A self-controlled case series analysis of national linked datasets from Scotland","volume":"51","author":"Blackburn","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Reed, C., Chaves, S.S., Daily Kirley, P., Emerson, R., Aragon, D., Hancock, E.B., Butler, L., Baumbach, J., Hollick, G., and Bennett, N.M. (2015). Estimating influenza disease burden from population-based surveillance data in the United States. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0118369"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"570681","DOI":"10.3389\/fimmu.2020.570681","article-title":"Immune Mechanisms in Cardiovascular Diseases Associated With Viral Infection","volume":"11","author":"Gopal","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.atherosclerosis.2009.07.028","article-title":"Influenza virus directly infects, inflames, and resides in the arteries of atherosclerotic and normal mice","volume":"208","author":"Haidari","year":"2010","journal-title":"Atherosclerosis"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1086\/656044","article-title":"Influenza virus-cytokine-protease cycle in the pathogenesis of vascular hyperpermeability in severe influenza","volume":"202","author":"Wang","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1161\/01.CIR.0000030182.35880.3E","article-title":"Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide","volume":"106","author":"Wagner","year":"2002","journal-title":"Circulation"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cytogfr.2008.11.003","article-title":"Interferon gamma: A master regulator of atherosclerosis","volume":"20","author":"McLaren","year":"2009","journal-title":"Cytokine Growth Factor. Rev."},{"key":"ref_95","first-page":"1717","article-title":"Systemic inflammation and arrhythmic risk: Lessons from rheumatoid arthritis","volume":"38","author":"Lazzerini","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.2013.279206","article-title":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: A meta-analysis","volume":"310","author":"Udell","year":"2013","journal-title":"JAMA"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.1016\/j.vaccine.2015.07.006","article-title":"Prevention of serious events in adults 65 years of age or older: A comparison between high-dose and standard-dose inactivated influenza vaccines","volume":"33","author":"DiazGranados","year":"2015","journal-title":"Vaccine"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"20656","DOI":"10.1038\/s41598-020-77679-7","article-title":"Protective effect of influenza vaccination on cardiovascular diseases: A systematic review and meta-analysis","volume":"10","author":"Zangiabadian","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"A24","DOI":"10.1016\/j.vaccine.2020.09.004","article-title":"Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: An updated systematic review and meta-analysis","volume":"39","author":"Lee","year":"2021","journal-title":"Vaccine"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e019636","DOI":"10.1161\/JAHA.120.019636","article-title":"Effects of Influenza Vaccine on Mortality and Cardiovascular Outcomes in Patients With Cardiovascular Disease: A Systematic Review and Meta-Analysis","volume":"10","author":"Yedlapati","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1161\/CIRCULATIONAHA.121.057534","article-title":"Am I Getting the Influenza Shot Too?: Influenza Vaccination as Post-Myocardial Infarction Care for the Prevention of Cardiovascular Events and Death","volume":"144","author":"Michos","year":"2021","journal-title":"Circulation"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41569-021-00670-w","article-title":"Universal flu vaccines: A shot at lifelong cardioprotection?","volume":"19","author":"Behrouzi","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jiph.2022.12.016","article-title":"Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar","volume":"16","author":"Tayar","year":"2023","journal-title":"J. Infect. Public. Health"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Taghioff, S.M., Slavin, B.R., Holton, T., and Singh, D. (2021). Examining the potential benefits of the influenza vaccine against SARS-CoV-2: A retrospective cohort analysis of 74,754 patients. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0255541"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1038\/s41598-021-83641-y","article-title":"Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations","volume":"11","author":"Pawlowski","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/vim.2017.0138","article-title":"The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza","volume":"31","author":"Smith","year":"2018","journal-title":"Viral Immunol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/S0163-4453(17)30199-8","article-title":"Generalized herd effects and vaccine evaluation: Impact of live influenza vaccine on off-target bacterial colonisation","volume":"74","author":"Mina","year":"2017","journal-title":"J. Infect."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.2217\/fca-2020-0188","article-title":"SARS-CoV-2 as an inflammatory cardiovascular disease: Current knowledge and future challenges","volume":"17","author":"Shah","year":"2021","journal-title":"Future Cardiol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/jama.2022.12992","article-title":"Association Between Vaccination and Acute Myocardial Infarction and Ischemic Stroke After COVID-19 Infection","volume":"328","author":"Kim","year":"2022","journal-title":"JAMA"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1001\/jamapediatrics.2018.4578","article-title":"Association of Rotavirus Vaccination With the Incidence of Type 1 Diabetes in Children","volume":"173","author":"Perrett","year":"2019","journal-title":"JAMA Pediatr."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1038\/s41598-019-44193-4","article-title":"Lower Incidence Rate of Type 1 Diabetes after Receipt of the Rotavirus Vaccine in the United States, 2001-2017","volume":"9","author":"Rogers","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"696734","DOI":"10.3389\/fimmu.2021.696734","article-title":"Mycobacterium-Induced Th1, Helminths-Induced Th2 Cells and the Potential Vaccine Candidates for Allergic Asthma: Imitation of Natural Infection","volume":"12","author":"Abdelaziz","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"872542","DOI":"10.3389\/fimmu.2022.872542","article-title":"Adult Vaccination as a Protective Factor for Dementia: A Meta-Analysis and Systematic Review of Population-Based Observational Studies","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41577-020-0338-x","article-title":"The non-specific and sex-differential effects of vaccines","volume":"20","author":"Aaby","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/S0140-6736(03)13771-3","article-title":"Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: Reanalysis of West African studies","volume":"361","author":"Aaby","year":"2003","journal-title":"Lancet"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"8130","DOI":"10.1128\/IAI.73.12.8130-8135.2005","article-title":"Th2-associated local reactions to the acellular diphtheria-tetanus-pertussis vaccine in 4- to 6-year-old children","volume":"73","author":"Rowe","year":"2005","journal-title":"Infect. Immun."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"176ra132","DOI":"10.1126\/scitranslmed.3005191","article-title":"Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination","volume":"5","author":"Bentebibel","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: From basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"9488","DOI":"10.1073\/pnas.95.16.9488","article-title":"Cell division regulates the T cell cytokine repertoire, revealing a mechanism underlying immune class regulation","volume":"95","author":"Gett","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_121","first-page":"330","article-title":"Seiches: Transient standing-wave oscillations in water bodies can create hazards to navigation and unexpected changes in water conditions","volume":"83","author":"Korgan","year":"1995","journal-title":"Am. Sci."},{"key":"ref_122","unstructured":"NOAA (2023, April 09). What Is a Seiche?, Available online: https:\/\/oceanservice.noaa.gov\/facts\/seiche.html."},{"key":"ref_123","unstructured":"NOAA (2023, April 09). What Is a Meteotsunami?, Available online: https:\/\/oceanservice.noaa.gov\/facts\/meteotsunami.html."},{"key":"ref_124","unstructured":"NOAA (2023, April 09). What Is a Tsunami?, Available online: https:\/\/oceanservice.noaa.gov\/facts\/tsunami.html."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1006\/smim.2000.0234","article-title":"Discrimination and dialogue in the immune system","volume":"12","author":"Cohen","year":"2000","journal-title":"Semin. Immunol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1056\/NEJMoa066092","article-title":"Duration of humoral immunity to common viral and vaccine antigens","volume":"357","author":"Amanna","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0264-410X(01)00328-0","article-title":"Acute and long-term effects of booster immunisation on frequencies of antigen-specific memory B-lymphocytes","volume":"20","author":"Nanan","year":"2001","journal-title":"Vaccine"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.1016\/j.vaccine.2010.07.056","article-title":"The kinetics of soluble and particulate antigen trafficking in the afferent lymph, and its modulation by aluminum-based adjuvant","volume":"28","author":"Kemp","year":"2010","journal-title":"Vaccine"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.addr.2020.06.019","article-title":"Controlling timing and location in vaccines","volume":"158","author":"Irvine","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/s41590-022-01328-6","article-title":"Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responses","volume":"23","author":"Hagan","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ni.2789","article-title":"Molecular signatures of antibody responses derived from a systems biology study of five human vaccines","volume":"15","author":"Li","year":"2014","journal-title":"Nat. Immunol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/s41590-022-01329-5","article-title":"Pan-vaccine analysis reveals innate immune endotypes predictive of antibody responses to vaccination","volume":"23","author":"Fourati","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1128\/CVI.00311-10","article-title":"The Th1 immune response to Plasmodium falciparum circumsporozoite protein is boosted by adenovirus vectors 35 and 26 with a homologous insert","volume":"17","author":"Radosevic","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-020-2814-7","article-title":"COVID-19 vaccine BNT162b1 elicits human antibody and T(H)1 T cell responses","volume":"586","author":"Sahin","year":"2020","journal-title":"Nature"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-020-01194-5","article-title":"T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1\/2 clinical trial","volume":"27","author":"Ewer","year":"2021","journal-title":"Nat. Med."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41541-021-00356-x","article-title":"Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic","volume":"6","author":"Mendonca","year":"2021","journal-title":"NPJ Vaccines"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S1473-3099(02)00222-0","article-title":"Superantigens: Microbial agents that corrupt immunity","volume":"2","author":"Llewelyn","year":"2002","journal-title":"Lancet Infect. Dis."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"101509","DOI":"10.1016\/j.isci.2020.101509","article-title":"The Whole Body as the System in Systems Immunology","volume":"23","author":"Poon","year":"2020","journal-title":"iScience"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/ni.3768","article-title":"Systems immunology: Just getting started","volume":"18","author":"Davis","year":"2017","journal-title":"Nat. Immunol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.cell.2017.04.026","article-title":"Metabolic Phenotypes of Response to Vaccination in Humans","volume":"169","author":"Li","year":"2017","journal-title":"Cell"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41590-022-01376-y","article-title":"SREBP signaling is essential for effective B cell responses","volume":"24","author":"Luo","year":"2023","journal-title":"Nat. Immunol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/ni.2067","article-title":"Systems biology of vaccination for seasonal influenza in humans","volume":"12","author":"Nakaya","year":"2011","journal-title":"Nat. Immunol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ni.1688","article-title":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans","volume":"10","author":"Querec","year":"2009","journal-title":"Nat. Immunol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-3083.2006.01805.x","article-title":"Impact of influenza vaccine formulation with a detailed analysis of the cytokine response","volume":"64","author":"Szyszko","year":"2006","journal-title":"Scand. J. Immunol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.vaccine.2016.11.059","article-title":"Greater activation of peripheral T follicular helper cells following high dose influenza vaccine in older adults forecasts seroconversion","volume":"35","author":"Pilkinton","year":"2017","journal-title":"Vaccine"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.immuni.2013.09.007","article-title":"Circulating precursor CCR7(lo)PD-1(hi) CXCR5(+) CD4(+) T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure","volume":"39","author":"He","year":"2013","journal-title":"Immunity"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cyto.2008.02.007","article-title":"Detection of Th1\/Th2 cytokine signatures in yellow fever 17DD first-time vaccinees through ELISpot assay","volume":"42","author":"Santos","year":"2008","journal-title":"Cytokine"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41586-021-03791-x","article-title":"Systems vaccinology of the BNT162b2 mRNA vaccine in humans","volume":"596","author":"Arunachalam","year":"2021","journal-title":"Nature"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"e136222","DOI":"10.1172\/JCI136222","article-title":"The knowns and unknowns of latent Mycobacterium tuberculosis infection","volume":"131","author":"Boom","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s41579-022-00763-4","article-title":"Immune evasion and provocation by Mycobacterium tuberculosis","volume":"20","author":"Chandra","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"6594","DOI":"10.1038\/s41467-022-34061-7","article-title":"Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants","volume":"13","author":"Satti","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2017.36","article-title":"The immunopathology of sepsis and potential therapeutic targets","volume":"17","author":"Scicluna","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fimmu.2013.00114","article-title":"Mechanisms of action of adjuvants","volume":"4","author":"Awate","year":"2013","journal-title":"Front. Immunol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.coi.2017.07.010","article-title":"Towards an evidence based approach for the development of adjuvanted vaccines","volume":"47","author":"Friedland","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s40264-015-0350-4","article-title":"Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs","volume":"38","author":"Petrovsky","year":"2015","journal-title":"Drug Saf."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat. Med."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1080\/21645515.2018.1495301","article-title":"Immunology and efficacy of MF59-adjuvanted vaccines","volume":"14","author":"Ko","year":"2018","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Facciola, A., Visalli, G., Lagana, A., and Di Pietro, A. (2022). An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives. Vaccines, 10.","DOI":"10.3390\/vaccines10050819"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"C457","DOI":"10.1152\/ajpcell.00247.2020","article-title":"Resolution of inflammation in immune and nonimmune cells by interleukin-19","volume":"319","author":"Leigh","year":"2020","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"eaax4517","DOI":"10.1126\/scitranslmed.aax4517","article-title":"BCG vaccination-induced emergency granulopoiesis provides rapid protection from neonatal sepsis","volume":"12","author":"Brook","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"21673","DOI":"10.1073\/pnas.1911464116","article-title":"IL-10-producing B cells are enriched in murine pericardial adipose tissues and ameliorate the outcome of acute myocardial infarction","volume":"116","author":"Wu","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1161\/01.RES.85.8.e17","article-title":"Protective role of interleukin-10 in atherosclerosis","volume":"85","author":"Mallat","year":"1999","journal-title":"Circ. Res."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41541-019-0132-6","article-title":"The how\u2019s and what\u2019s of vaccine reactogenicity","volume":"4","author":"Herve","year":"2019","journal-title":"NPJ Vaccines"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1086\/317513","article-title":"Circulating cytokines as mediators of fever","volume":"31","author":"Netea","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.vaccine.2010.12.090","article-title":"Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes","volume":"29","author":"Calabro","year":"2011","journal-title":"Vaccine"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.vaccine.2011.01.011","article-title":"Adjuvant System AS03 containing alpha-tocopherol modulates innate immune response and leads to improved adaptive immunity","volume":"29","author":"Morel","year":"2011","journal-title":"Vaccine"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1164\/rccm.201510-2000OC","article-title":"The Effects of Live Attenuated Influenza Vaccine on Nasopharyngeal Bacteria in Healthy 2 to 4 Year Olds. A Randomized Controlled Trial","volume":"193","author":"Thors","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Bigay, J., Le Grand, R., Martinon, F., and Maisonnasse, P. (2022). Vaccine-associated enhanced disease in humans and animal models: Lessons and challenges for vaccine development. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.932408"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"882972","DOI":"10.3389\/fimmu.2022.882972","article-title":"Vaccine-Associated Enhanced Disease and Pathogenic Human Coronaviruses","volume":"13","author":"Gartlan","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1084\/jem.146.1.201","article-title":"Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody","volume":"146","author":"Halstead","year":"1977","journal-title":"J. Exp. Med."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1126\/science.1185181","article-title":"Cross-reacting antibodies enhance dengue virus infection in humans","volume":"328","author":"Dejnirattisai","year":"2010","journal-title":"Science"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1800820","article-title":"Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy","volume":"379","author":"Sridhar","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/S1473-3099(18)30494-8","article-title":"Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine","volume":"19","author":"Hombach","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.294.16.2043","article-title":"Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine","volume":"294","author":"Lexau","year":"2005","journal-title":"JAMA"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"e735","DOI":"10.1016\/S2666-5247(22)00158-6","article-title":"Emergence of a multidrug-resistant and virulent Streptococcus pneumoniae lineage mediates serotype replacement after PCV13: An international whole-genome sequencing study","volume":"3","author":"Lo","year":"2022","journal-title":"Lancet Microbe"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1473-3099(18)30052-5","article-title":"Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000\u20132017: A prospective national observational cohort study","volume":"18","author":"Ladhani","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268806007096","article-title":"The Lyme vaccine: A cautionary tale","volume":"135","author":"Nigrovic","year":"2007","journal-title":"Epidemiol. Infect."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1147476","DOI":"10.3389\/fimmu.2023.1147476","article-title":"Trained immunity: A \"new\" weapon in the fight against infectious diseases","volume":"14","author":"Dagenais","year":"2023","journal-title":"Front. Immunol."},{"key":"ref_180","first-page":"612269","article-title":"A Combination of Polybacterial MV140 and Candida albicans V132 as a Potential Novel Trained Immunity-Based Vaccine for Genitourinary Tract Infections","volume":"11","author":"Subiza","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Montalb\u00e1n-Hern\u00e1ndez, K., Cogollo-Garc\u00eda, A., Gir\u00f3n de Velasco-Sada, P., Caballero, R., Casanovas, M., Subiza, J.L., and Conejero, L. (2024). MV130 in the Prevention of Recurrent Respiratory Tract Infections: A Retrospective Real-World Study in Children and Adults. Vaccines, 12.","DOI":"10.3390\/vaccines12020172"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.3389\/fimmu.2018.02936","article-title":"Trained Immunity-Based Vaccines: A New Paradigm for the Development of Broad-Spectrum Anti-infectious Formulations","volume":"9","author":"Conejero","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"716296","DOI":"10.3389\/fimmu.2021.716296","article-title":"Editorial: Trained Immunity-Based Vaccines","volume":"12","author":"Subiza","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_184","first-page":"611946","article-title":"Induction of Trained Immunity by Recombinant Vaccines","volume":"11","author":"Bueno","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"612747","DOI":"10.3389\/fimmu.2021.612747","article-title":"Optimize Prime\/Boost Vaccine Strategies: Trained Immunity as a New Player in the Game","volume":"12","author":"Palgen","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0140-6736(02)65402-9","article-title":"On smallpox and vaccination in India","volume":"93","author":"Pringle","year":"1869","journal-title":"Lancet"},{"key":"ref_187","unstructured":"WHO (2014). Meeting of the Strategic advisory group of experts on immunization, April 2014\u2014Conclusions and recommendations. Wkly. Epidemiol. Rec., 89, 233\u2013235."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"eadf1093","DOI":"10.1126\/scitranslmed.adf1093","article-title":"Vaccines for a sustainable planet","volume":"15","author":"Pecetta","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41579-020-00506-3","article-title":"The role of vaccines in combatting antimicrobial resistance","volume":"19","author":"Micoli","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/S2666-5247(22)00303-2","article-title":"The role of bacterial vaccines in the fight against antimicrobial resistance: An analysis of the preclinical and clinical development pipeline","volume":"4","author":"Frost","year":"2023","journal-title":"Lancet Microbe"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/4\/396\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:25:10Z","timestamp":1760106310000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/4\/396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,9]]},"references-count":190,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["vaccines12040396"],"URL":"https:\/\/doi.org\/10.3390\/vaccines12040396","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,9]]}}}